|
Volumn 46, Issue 1, 2004, Pages 133-134
|
Re: Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol 2003;44:650-5 [1] (multiple lettes)
a
Box 11B
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
FINASTERIDE;
CANCER;
CANCER GRADING;
CANCER PREVENTION;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE SEVERITY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
TREATMENT OUTCOME;
ENZYME INHIBITORS;
EUROPE;
FINASTERIDE;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
UNITED STATES;
|
EID: 2942534495
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1016/j.eururo.2004.03.008 Document Type: Letter |
Times cited : (1)
|
References (0)
|